These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2999126

  • 1. trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor.
    Hwang SB, Lam MH, Biftu T, Beattie TR, Shen TY.
    J Biol Chem; 1985 Dec 15; 260(29):15639-45. PubMed ID: 2999126
    [Abstract] [Full Text] [Related]

  • 2. The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor.
    Shen TY, Hwang SB, Chang MN, Doebber TW, Lam MH, Wu MS, Wang X.
    Int J Tissue React; 1985 Dec 15; 7(5):339-43. PubMed ID: 2997065
    [Abstract] [Full Text] [Related]

  • 3. Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.
    Shen TY, Hwang SB, Chang MN, Doebber TW, Lam MH, Wu MS, Wang X, Han GQ, Li RZ.
    Proc Natl Acad Sci U S A; 1985 Feb 15; 82(3):672-6. PubMed ID: 2983307
    [Abstract] [Full Text] [Related]

  • 4. Species difference in the specific receptors of platelet activating factor.
    Hwang SB, Lam MH.
    Biochem Pharmacol; 1986 Dec 15; 35(24):4511-8. PubMed ID: 3024653
    [Abstract] [Full Text] [Related]

  • 5. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
    Hwang SB, Li CL, Lam MH, Shen TY.
    Lab Invest; 1985 Jun 15; 52(6):617-30. PubMed ID: 3925239
    [Abstract] [Full Text] [Related]

  • 6. Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
    Hwang SB, Lam MH, Hsu AH.
    Mol Pharmacol; 1989 Jan 15; 35(1):48-58. PubMed ID: 2536468
    [Abstract] [Full Text] [Related]

  • 7. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
    Hwang SB, Lam MH, Alberts AW, Bugianesi RL, Chabala JC, Ponpipom MM.
    J Pharmacol Exp Ther; 1988 Aug 15; 246(2):534-41. PubMed ID: 2841449
    [Abstract] [Full Text] [Related]

  • 8. (+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist.
    Ponpipom MM, Hwang SB, Doebber TW, Acton JJ, Alberts AW, Biftu T, Brooker DR, Bugianesi RL, Chabala JC, Gamble NL.
    Biochem Biophys Res Commun; 1988 Feb 15; 150(3):1213-20. PubMed ID: 2829894
    [Abstract] [Full Text] [Related]

  • 9. Ionic and GTP regulation of binding of platelet-activating factor to receptors and platelet-activating factor-induced activation of GTPase in rabbit platelet membranes.
    Hwang SB, Lam MH, Pong SS.
    J Biol Chem; 1986 Jan 15; 261(2):532-7. PubMed ID: 3001070
    [Abstract] [Full Text] [Related]

  • 10. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
    Hwang SB, Lam MH, Szalkowski DM, MacIntyre DE, Bach TJ, Luell S, Meuer R, Sahoo SP, Alberts AW, Chabala JC.
    J Lipid Mediat; 1993 Jun 15; 7(2):115-34. PubMed ID: 8400114
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist.
    Yamada T, Saito M, Mase T, Hara H, Nagaoka H, Murase K, Tomioka K.
    Lipids; 1991 Dec 15; 26(12):1179-83. PubMed ID: 1668114
    [Abstract] [Full Text] [Related]

  • 12. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
    Nunez D, Chignard M, Korth R, Le Couedic JP, Norel X, Spinnewyn B, Braquet P, Benveniste J.
    Eur J Pharmacol; 1986 Apr 16; 123(2):197-205. PubMed ID: 3086108
    [Abstract] [Full Text] [Related]

  • 13. Specific binding of [3H]dihydrokadsurenone to rabbit platelet membranes and its inhibition by the receptor agonists and antagonists of platelet-activating factor.
    Hwang SB, Lam MH, Chang MN.
    J Biol Chem; 1986 Oct 15; 261(29):13720-6. PubMed ID: 3020044
    [Abstract] [Full Text] [Related]

  • 14. Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet.
    Terashita Z, Imura Y, Nishikawa K.
    Biochem Pharmacol; 1985 May 01; 34(9):1491-5. PubMed ID: 2986648
    [Abstract] [Full Text] [Related]

  • 15. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM, Bernat A, Valette G, Gigo V, Lale A, LaPlace MC, Lespy L, Savi P, Maffrand JP, Le Fur G.
    J Pharmacol Exp Ther; 1991 Oct 01; 259(1):44-51. PubMed ID: 1656029
    [Abstract] [Full Text] [Related]

  • 16. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets.
    Robaut C, Durand G, James C, Lave D, Sedivy P, Floch A, Mondot S, Pacot D, Cavero I, Le Fur G.
    Biochem Pharmacol; 1987 Oct 01; 36(19):3221-9. PubMed ID: 2822048
    [Abstract] [Full Text] [Related]

  • 17. [Antagonists of platelet activating factor].
    Tokumura A, Tsukatani H.
    Seikagaku; 1985 Dec 01; 57(12):1618-23. PubMed ID: 3009656
    [No Abstract] [Full Text] [Related]

  • 18. Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes.
    Hwang SB.
    J Biol Chem; 1988 Mar 05; 263(7):3225-33. PubMed ID: 2830276
    [Abstract] [Full Text] [Related]

  • 19. A specific, photolabile and irreversible antagonist (L662,025) of the PAF-receptor.
    Hussaini IM, Shen TY.
    Biochem Biophys Res Commun; 1989 May 30; 161(1):23-30. PubMed ID: 2543410
    [Abstract] [Full Text] [Related]

  • 20. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
    Doebber TW, Wu MS, Biftu T.
    J Immunol; 1986 Jun 15; 136(12):4659-68. PubMed ID: 3011900
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.